Lynx1 Capital Management LP bought $79k of KRRO
owner at Korro Bio, Inc.. 6,684 shares at an average of $11.79, traded Aug 6, 2026, filed Aug 13, 2026.
Score components
- +12Role10% owner
- +9Trade size$79k at market
- -5Relative to holdingsUnder 1% of holdings (0.4%)
- +8Price context76% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- +5Track recordMedian 6-month excess return +1% over 12 past buys
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000902664-26-003434, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | POpen-market purchase Common stock, $0.001 par value per shareindirect: See footnote | +5,222 | $11.40 | $60k | 1,543,518 | Aug 13, 2026 |
| Aug 10, 2026 | POpen-market purchase Common stock, $0.001 par value per shareindirect: See footnote | +1,462 | $13.19 | $19k | 1,544,980 | Aug 13, 2026 |
Related signals
Other insiders at Korro Bio, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | Korro Bio, Inc. | Jean Francois Formela director | $686k 48,690 shares | -7% | |
| 3Weak | Korro Bio, Inc. | Oliver Dolan Senior Vice President, Finance | $69 5 shares | -0% | |
| 23Weak | Korro Bio, Inc. | Oliver Dolan Senior Vice President, Finance | $99k 7,353 shares | -31% | |
| 3Weak | Korro Bio, Inc. | Jean Francois Formela director | $4,188 300 shares | -0% | |
| 11Weak | Korro Bio, Inc. | Jean Francois Formela director | $399k 28,468 shares | -4% | |
| 8Weak | Korro Bio, Inc. | Jean Francois Formela director | $30k 2,143 shares | -0% | |
| 41Moderate | Korro Bio, Inc. | Ram Aiyar President and CEO | $63k 5,802 shares | -8% | |
| 25Weak | Korro Bio, Inc. | Jean Francois Formela director | $1.5M 110,023 shares | -14% | |
| 40Moderate | Korro Bio, Inc. | Jean Francois Formela director | $2.5M 171,405 shares | -18% | |
| 43Moderate | Korro Bio, Inc. | Jeffrey Cerio General Counsel | $72k 6,609 shares | -16% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.